COPD Prognosis in Covid Patients
March 9, 2022 updated by: Islam Mokhtar Ahmed, Sohag University
Chronic Obstructive Pulmonary Disease Prognosis in Sars-covid 2 Infection
In this prospective observational study, patients were selected from attendees of the intensive care unit.
Different measures and outcomes had been studied and compared between patients with and without COPD, including hospitalization, medical costs, length of Intensive care stay, respiratory failure, and death rate.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sohag, Egypt
- Faculty of medicine, Sohag university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
male or female patient more than 20 years old, recently diagnosed covid positive
Description
Inclusion Criteria:
Age: more than 20 years old.
- Both Males and females will be included.
- COPD patients.
- Recent confirmed the diagnosis with SARS-COV-2.
Exclusion Criteria:
Pregnancy.
- Malignancy.
- Immunodeficiency disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
copd patients with covid infection
|
patients who were in need were intubated and mechanically ventilated
|
|
non-copd patients with covid infection
|
patients who were in need were intubated and mechanically ventilated
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SOFA score measurement in both groups
Time Frame: 2 weeks
|
monitoring of SOFA items along two weeks
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
prognosis of the disease
Time Frame: 2 weeks
|
hospital stay, nedd for mechanical ventilation
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2021
Primary Completion (Actual)
December 1, 2021
Study Completion (Actual)
January 1, 2022
Study Registration Dates
First Submitted
March 5, 2022
First Submitted That Met QC Criteria
March 9, 2022
First Posted (Actual)
March 10, 2022
Study Record Updates
Last Update Posted (Actual)
March 10, 2022
Last Update Submitted That Met QC Criteria
March 9, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- soh-Med-22-1-26
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.